
Diego Martins
@dap_martins
PhD student at the Schuringa Lab - CRCG. Researcher focused on molecular markers of therapy response in Myeloid Leukemias.
ID: 851263307319132165
10-04-2017 02:39:22
116 Tweet
124 Followers
593 Following

I am very grateful to the YoungEHA committee for this opportunity to share this great collaborative work from the Schuringa Lab, #RegoLab, and Myeloid Leukaemia Genomics and Biology Group on metabolism in AML! Looking forward to the next talks at #EHA2024!

Fantastic talk from Jan Jacob Schuringa on the latest data from the Schuringa Lab about the metabolic heterogeneity in AMLs and the role of the tumor microenvironment on metabolic abnormalities/adaptation in AML at #EHA2024!



Finishing #EHA2024 with this amazing opportunity to present our latest results on MN1-driven AMLs! Very grateful to the European Hematology Association scientific committee, to my mentor Jan Jacob Schuringa and all the members of the Schuringa Lab, Myeloid Leukaemia Genomics and Biology Group and #RegoLab that contributed to this story!





🔎 Investigators with Dr. Vilma Dembitz at Barts Cancer Institute (Queen Mary) identified stearoyl-CoA desaturase as prognostic of patients' outcomes and showed that SCD inhibition ⛔ is a therapeutic vulnerability across multiple #AML models. Leukemia Journal | go.nature.com/4g44ssH



Why do AML patients with African ancestry have poor outcomes? Fascinating results indicate that genetics alter AML biology. Also, its Bailee Kain's first co-first author postdoc pub. Bailee Kain AK Eisfeld Nathan Salomonis and Elaine Mardis nature.com/articles/s4158…


We are at the #ASH2024! Check out today poster #1393 about the role of lipid metabolism in metformin sensitivity in AML from Dominique Sternadt and #1539 with the mechanisms of MLL5-driven leukemic transformation from LuÃse Simões

Great ending for the first day at #ASH2024 with this group that keeps growing every year! Great to see you all! Schuringa Lab Myeloid Leukaemia Genomics and Biology Group



So happy to present our work at the #ASH24! I’m very honoured to be a recipient of the abstract achievement award this year. Many thanks to all the collaborators involved in this project Schuringa Lab Myeloid Leukaemia Genomics and Biology Group FrezzaLab Sarry Lab


Fantastic talk from Dr. Zheng from the Myeloid Leukaemia Genomics and Biology Group on the role of TP53 mutations in CH-associated dyserythropoiesis and OxPhos alterations!




Review from the lab on lipid metabolism in AML just out Leukemia Journal rdcu.be/em651 Led by the hard work of Vilma Dembitz and Sophie James Hope you enjoy the read!

Excited to announce a new paper in Cancer Discovery with Junwei Shi, Zhendong (Tom) Cao, Anthony Daniyan and led by Pu Zhang. We perform screens of GAPs and GEFs in AML and discover a hematopoietic-specific GAP (ARHGAP45) required in AML: aacrjournals.org/cancerdiscover…
